THE MEPHENYTOIN (CYTOCHROME-P450 2C-19) AND DEXTROMETHORPHAN (CYTOCHROME-P450 2D6) POLYMORPHISMS IN SAUDI-ARABIANS AND FILIPINOS

被引:0
作者
EVANS, DAP [1 ]
KRAHN, P [1 ]
NARAYANAN, N [1 ]
机构
[1] KING FAISAL SPECIALIST HOSP & RES CTR,RIYADH 11211,SAUDI ARABIA
来源
PHARMACOGENETICS | 1995年 / 5卷 / 02期
关键词
SAUDI ARABIA; POLYMORPHISM (GENETICS); MEPHENYTOIN; DEXTROMETHORPHAN;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hitherto no estimate has been available of the genetic polymorphisms of S-mephenytoin hydroxylation in the Saudi Arabian or any other Middle Eastern population, A total of 102 healthy Saudi Arabian volunteer subjects were tested simultaneously with mephenytoin and dextromethorphan. Two poor metabolizers of S-mephenytoin and two poor metabolizers of dextromethorphan were found. Also 55 healthy Filipino volunteer subjects were tested and 13 found to be poor metabolizers of S-mephenytoin, whilst none were found to be poor metabolizers of dextromethorphan, The Saudi Arabian population thus appears to resemble Europeans in the frequency of poor metabolizers of S-mephenytoin, but resembles Orientals in the frequency of poor metabolizers of dextromethorphan. The Filipino sample as expected resembles other Oriental samples in the frequencies of poor metabolizers of both drugs.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 40 条
[1]  
ADEDOYIN A, 1994, PHARMACOGENETICS, V4, P27
[2]   HYDROXYLATION POLYMORPHISMS OF DEBRISOQUINE AND MEPHENYTOIN IN EUROPEAN POPULATIONS [J].
ALVAN, G ;
BECHTEL, P ;
ISELIUS, L ;
GUNDERTREMY, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) :533-537
[3]  
ALVAN G, 1990, EUR J CLIN PHARMACOL, V38, P533
[4]   SLOW OMEPRAZOLE METABOLIZERS ARE ALSO POOR S-MEPHENYTOIN HYDROXYLATORS [J].
ANDERSSON, T ;
REGARDH, CG ;
DAHLPUUSTINEN, ML ;
BERTILSSON, L .
THERAPEUTIC DRUG MONITORING, 1990, 12 (04) :415-416
[5]   DEXTROMETHORPHAN AND MEPHENYTOIN PHENOTYPING OF PATIENTS TREATED WITH THIORIDAZINE OR AMITRIPTYLINE [J].
BAUMANN, P ;
MEYER, JW ;
AMEY, M ;
BAETTIG, D ;
BRYOIS, C ;
JONZIERPEREY, M ;
KOEB, L ;
MONNEY, C ;
WOGGON, B .
THERAPEUTIC DRUG MONITORING, 1992, 14 (01) :1-8
[6]   PRONOUNCED DIFFERENCES BETWEEN NATIVE CHINESE AND SWEDISH POPULATIONS IN THE POLYMORPHIC HYDROXYLATIONS OF DEBRISOQUIN AND S-MEPHENYTOIN [J].
BERTILSSON, L ;
LOU, YQ ;
DU, YL ;
LIU, Y ;
KUANG, TY ;
LIAO, XM ;
WANG, KY ;
REVIRIEGO, J ;
ISELIUS, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (04) :388-397
[7]  
BREIMER DD, 1988, MICROSOMES DRUG OXID, P232
[8]   PROGUANIL METABOLISM IS DETERMINED BY THE MEPHENYTOIN OXIDATION POLYMORPHISM IN VIETNAMESE LIVING IN DENMARK [J].
BROSEN, K ;
SKJELBO, E ;
FLACHS, H .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (02) :105-108
[9]  
DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419
[10]   FREQUENCY OF IMPAIRED MEPHENYTOIN 4'-HYDROXYLATION IN AN INDIAN POPULATION [J].
DOSHI, BS ;
KULKARNI, RD ;
CHAUHAN, BL ;
WILKINSON, GR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (05) :779-780